Breast Cancer Update .com - Special Report: 21st Annual Miami Breast Cancer Conference 2004

You are here: Home: Special Report: 21st Annual Miami Breast Cancer Conference 2004:
D: Adjuvant Endocrine Therapy in Postmenopausal Patients: Sequencing Tamoxifen and Aromatase Inhibitors: Select publications

Select publications

Boccardo F et al. Anastrozole appears to be superior to tamoxifen in women already receiving adjuvant tamoxifen treatment. Breast Cancer ResTreat 2003; Abstract 3.

Boccardo F et al. Sequential tamoxifen and aminoglutethimide versus tamoxifen alone in the adjuvant treatment of postmenopausal breast cancer patients: results of an Italian cooperative study. J Clin Oncol 2001;19(22):4209-15. Abstract

Goss PE et al. A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer. N Engl J Med 2003;349(19):1793-802. Abstract

Table of Contents

Top of Page

Loews Miami Beach Hotel Miami Beach, Florida February 25 - 28, 2004
Editor’s Note: Bringing out the vote
Tumor Panel Cases Keypad Results

A:	Breast Cancer Prevention - Select publications

B:	HER2 Assessment - Select publications

C:	Adjuvant Endocrine Therapy in Postmenopausal Patients: ATAC - Select publications

D:	Adjuvant Endocrine Therapy in Postmenopausal Patients: Sequencing Tamoxifen and Aromatase Inhibitors - Select publications

E:	Adjuvant Chemotherapy in the Elderly - Select publications

F:	Clinical Trials of Adjuvant Trastuzumab - Select publications

G:	Sequencing Endocrine Therapy in Metastatic Disease - Select publications

H:	Ductal Carcinoma In Situ - Select publications

I:	Adjuvant Endocrine Therapy: Premenopausal Patients - Select publications

J:	Chemotherapy in Metastatic Breast Cancer - Select publications

Home · Contact us

Terms of use and general disclaimer